Towards delineating functions within the Fasciola Secreted Cathepsin L protease family by integrating in vivo based sub-proteomics and phylogenetics

PLoS Neglected Tropical Diseases

Volumn 5, Issue 1, 2011, Pages

  Morphew, Russell M ^a   Wright, Hazel A ^a   LaCourse, E James ^b   Porter, Joanne ^c   Barrett, John ^a   Woods, Debra J ^d   Brophy, Peter M ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c HERIOT WATT UNIVERSITY   (United Kingdom)

^d ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L;

ANIMAL TISSUE; ARTICLE; CLADISTICS; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ASSAY; ENZYME RELEASE; EXPRESSED SEQUENCE TAG; FASCIOLA HEPATICA; FUNCTIONAL PROTEOMICS; GENETIC VARIABILITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE EXAMINATION; PHYLOGENY; PRODUCT DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN TARGETING; SCREENING TEST; SENSITIVITY ANALYSIS; SHEEP; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UNINDEXED SEQUENCE; VACCINE PRODUCTION; ANIMAL; BILE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; GOAT; ISOLATION AND PURIFICATION; METABOLISM; PARASITOLOGY; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BILE; CATHEPSIN L; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FASCIOLA HEPATICA; GENE EXPRESSION PROFILING; GOATS; PHYLOGENY; PROTEOMICS;

EID: 79851480891     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000937     Document Type: Article

References (63)

1. Dawes B (1963) The migration of juvenile forms of Fasciola hepatica L. through the wall of the intestines in the mouse, with some observations on food and feeding. Parasitology 53: 109-122.
2. Boray JC (1997) Chemotherapy of infections with fasciolidae. In: Boray JC, editors. Immunology, pathobiology and control of Fasciolosis New Jersey MSD AGVET Rahway pp. 83-97.
3. Curtale F, Hassanein YA, Savioli L (2005) Control of Human Fascioliasis by Selective Chemotherapy: Design, Cost and Effect of the First Public Health, School-Based Intervention Implemented in Endemic Areas of the Nile Delta, Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene 99: 599-609.
4. Hopkins DR (1992) Homing in on Helminths. American Journal of Tropical Medicine and Hygiene 46: 626-634.
5. Mas-Coma MS, Esteban JG, Bargues MD (1999) Epidemiology of Human Fascioliasis: A Review and Proposed New Classification. Bulletin of the World Health Organization 77: 340-346.
6. Anonymous (1995) Control of foodborne trematode infections Geneva WHO.
7. WHO (2006) Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control Geneva WHO Headquarters http://www.who.int/neglected_diseases/preventive_chemotherapy/WHO_CDS_NTD_PCT_2007.1.pdf.
8. WHO (2007) Action Against worms. http://www.who.int/neglected_diseases/preventive_chemotherapy/Newsletter10.pdf.
9. Moll L, Gaasenbeek CPH, Vellema P, Borgsteede FHM (2000) Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Veterinary Parasitology 91: 153-158.
10. Mitchell GBB, Maris L, Bonniwell MA (1998) Triclabendazole-resistant liver fluke in Scottish sheep. Veterinary Record 143: 399-399.
11. Thomas I, Coles GC, Duffus K (2000) Triclabendazole-resistant Fasciola hepatica in southwest Wales. Veterinary Record 146: 200-200.
12. Brennan GP, Fairweather I, Trudgett A, Hoey E, McCoy, et al. (2007) Understanding triclabendazole resistance. Experimental and Molecular Pathology 82: 104-109.
13. Mulcahy G, Dalton JP (1998) Vaccines in the control of liver fluke infection in ruminants: Current status and prospects. Irish Veterinary Journal 51: 520-525.
14. Morphew RM, Wright HA, LaCourse EJ, Woods DJ, Brophy PM (2007) Comparative Proteomics of Excretory-Secretory Proteins Released by the Liver Fluke Fasciola hepatica in Sheep Host Bile and During In Vitro Culture Ex-Host. Molecular & Cellular Proteomics 6: 963-972.
15. Jefferies JR, Campbell AM, Van Rossum AJ, Barrett J, Brophy PM (2001) Proteomic analysis of Fasciola hepatica excretory-secretory products. Proteomics 1: 1128-1132.
16. Dalton JP, Neill SO, Stack C, Collins P, Walshe A, et al. (2003) Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. International Journal for Parasitology 33: 1173-1181.
17. Harmsen MM, Cornelissen J, Buijs H, Boersma WJA, Jeurissen SHM, et al. (2004) Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. International Journal for Parasitology 34: 675-682.
18. Cancela M, Acosta D, Rinaldi G, Silva E, Duran R, et al. (2008) A Distinctive Repertoire of Cathepsins is Expressed by Juvenile Invasive Fasciola hepatica. Biochimie 90: 1461-1475.
19. Tort J, Brindley PJ, Knox D, Wolfe KH, Dalton JP (1999) Proteinases and associated genes of parasitic helminths. Advances in Parasitology, Vol 43 San Diego Academic Press Inc pp. 161-266.
20. Wijffels GL, Panaccio M, Salvatore L, Wilson L, Walker ID, et al. (1994) The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochemical Journal 299: 781-790.
21. Roche L, Dowd AJ, Tort J, McGonigle S, McSweeney A, et al. (1997) Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiae. European Journal of Biochemistry 245: 373-380.
22. Heussler VT, Dobbelaere DAE (1994) Cloning of a protease gene family of Fasciola hepatica by the polymerase chain reaction. Molecular and Biochemical Parasitology 64: 11-23.
23. Irving JA, Spithill TW, Pike RN, Whisstock JC, Smooker PM (2003) The evolution of enzyme specificity in Fasciola spp. Journal of Molecular Evolution 57: 1-15.
24. Robinson MW, Tort JF, Lowther J, Donnelly SM, Wong E, et al. (2008) Proteomic and phylogenetic analysis of the cathepsin L protease family of the helminth pathogen, Fasciola hepatica: expansion of a repertoire of virulence-associated factors. Molecular and Cellular Proteomics 7: 1111-1123.
25. Chemale G, Morphew R, Moxon JV, Morassuti AL, LaCourse EJ, et al. (2006) Proteomic analysis of glutathione transferases from the liver fluke parasite, Fasciola hepatica. Proteomics 6: 6263-6273.
26. Dalton JP, Brindley PJ, Knox DP, Brady CP, Hotez PJ, et al. (2003) Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. International Journal for Parasitology 33: 621-640.
27. Beeson JG, Crabb BS (2007) Towards a vaccine against Plasmodium vivax malaria. Plos Medicine 4: 1862-1864.
28. VanBuskirk KM, Cole-Tobian JL, Baisor M, Sevova ES, Bockarie M, et al. (2004) Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. Journal of Infectious Diseases 190: 1556-1562.
29. Gorg A, Postel W, Weser J, Gunther S, Strahler JR, et al. (1987) Elimination of point streaking on silver stained two-dimensional gels by addition of iodoacetamide to the equilibration buffer. Electrophoresis 8: 122-124.
30. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Analytical Chemistry 68: 850-858.
31. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. Journal of Molecular Biology 215: 403-410.
32. Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. 41: 95-98.
33. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. Journal of Molecular Biology 340: 783-795.
34. Kolaskar AS, Tongaonkar PC (1990) A Semiempirical Method For Prediction Of Antigenic Determinants On Protein Antigens. FEBS Letters 276: 172-174.
35. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 25: 4876-4882.
36. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular Biology and Evolution Available online 10.1093/molbev/msm092.
37. Turk D, Guncar G, Podobnik M, Turk B (1998) Revised definition of substrate binding sites of papain-like cysteine proteases. Biological Chemistry 379: 137-147.
38. Robinson MW, Tort JF, Lowther J, Donnelly SM, Wong E, et al. (2008) Proteomic and phylogenetic analysis of the cathepsin L protease family of the helminth pathogen, Fasciola hepatica: expansion of a repertoire of virulence-associated factors. Molecular and Cellular Proteomics February 21, 2008, 10.1074/mcp.M700560-MCP200.
39. Collins PR, Stack CM, O'Neill SM, Doyle S, Ryan T, et al. (2004) Cathepsin L1, the Major Protease Involved in Liver Fluke (Fasciola hepatica) Virulence: Propeptide Cleavage Sites and Autoactivation of the Zymogen Secreted from Gastrodermal Cells. Journal of Biological Chemistry 279: 17038-17046.
40. Dalton JP, Caffrey CR, Sajid M, Stack C, Donnelly S, et al. (2006) Proteases in trematode biology. In: Maule AG, Marks NJ, editors. Parasitic flatworms: molecular biology, biochemistry, immunology and physiology Wallingford C. A. B. International pp. 348-368.
41. Robinson MW, Dalton JP, Donnelly S (2008) Helminth pathogen cathepsin proteases: it's a family affair. Trends in Biochemical Sciences 33: 601-608.
42. Robinson MW, Menon R, Donnelly SM, Dalton JP, Ranganathan S (2009) An Integrated Transcriptomics and Proteomics Analysis of the Secretome of the Helminth Pathogen Fasciola hepatica: Proteins Associated With Invasion and Infection of the Mammalian Host. Molecular & Cellular Proteomics 8: 1891-1907.
43. Panaccio M, Trudgett A (1999) Molecular biology and Fasciola hepatica. In: Dalton JP, editors. Fasciolosis Oxford C. A. B. International pp. 449-464.
44. Fletcher HL, Hoey EM, Orr N, Trudgett A, Fairweather I, et al. (2004) The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica. Parasitology 128: 69-72.
45. Grams R, Vichasri-Grams S, Sobhon P, Upatham ES, Viyanant V (2001) Molecular Cloning and Characterization of Cathepsin L Encoding Genes from Fasciola gigantica. Parasitology International 50: 105-114.
46. Berasain P, Carmona C, Frangione B, Dalton JP, Goni F (2000) Fasciola hepatica: Parasite-secreted proteinases degrade all human IgG subclasses: Determination of the specific cleavage sites and identification of the immunoglobulin fragments produced. Experimental Parasitology 94: 99-110.
47. Lowther J, Robinson MW, Donnelly SM, Xu WB, Stack CM, et al. (2009) The Importance of pH in Regulating the Function of the Fasciola hepatica Cathepsin L1 Cysteine Protease. Plos Neglected Tropical Diseases 3.
48. Ferre I, OrtegaMora LM, RojoVazquez FA (1997) Serum and Bile Antibody Responses (IgG and IgA) During Subclinical Fasciola hepatica Infection in Sheep. Veterinary Parasitology 68: 261-267.
49. Hughes DL, Hanna REB, Symonds HW (1981) Fasciola hepatica: IgG and IgA Levels in the Serum and Bile of Infected Cattle. Experimental Parasitology 52: 271-279.
50. Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, et al. (2008) Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica. Journal of Biological Chemistry 283: 9896-9908.
51. UCL (2008) The Single Amino Acid Polymorphism Database: SAAPdb. http://www.bioinf.org.uk/saap/.
52. Polson HEJ, Conway DJ, Fandeur T, Mercereau-Puijalon O, Longacre S (2005) Gene polymorphism of Plasmodium falciparum merozoite surface proteins 4 and 5. Molecular and Biochemical Parasitology 142: 110-115.
53. Claerebout E, Vercruysse J (2003) Assessment of the efficacy of helminth vaccines. Journal of Parasitology 89: S202-S209.
54. Spithill TW, Dalton JP (1998) Progress in development of liver fluke vaccines. Parasitology Today 14: 224-228.
55. Reszka N, Cornelissen J, Harmsen MM, Bienkowska-Szewczyk K, de Bree J, et al. (2005) Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis. Vaccine 23: 2987-2993.
56. Jayaraj R, Piedrafita D, Dynon K, Grams R, Spithill TW, et al. (2009) Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens. Veterinary Parasitology 160: 230-236.
57. Piacenza L, Acosta D, Basmadjian I, Dalton JP, Carmona C (1999) Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against Fascioliasis in sheep. Infection and Immunity 67: 1954-1961.
58. Dalton JP, McGonigle S, Rolph TP, Andrews SJ (1996) Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infection and Immunity 64: 5066-5074.
59. Deitsch KW, Moxon ER, Wellems TE (1997) Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiology and Molecular Biology Reviews 61: 281-293.
60. Golden O, Flynn RJ, Read C, Sekiya M, Donnelly SM, et al. (2010) Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine 28: 5551-5557.
61. Smooker PM, Whisstock JC, Irving JA, Siyaguna S, Spithill TW, et al. (2000) A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica. Protein Science 9: 2567-2572.
62. Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, et al. (1996) Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. Embo Journal 15: 5492-5503.
63. Thompson JD, Higgins DG, Gibson TJ (1994) Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 22: 4673-4680.